Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to explore functional consequences of migraine gene mutations
on their responses to Calcitonin Gene Related Peptide (CGRP)infusion.